The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.
<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI |
id |
doaj-aa495a98a1384a2da58609f3fa5db022 |
---|---|
record_format |
Article |
spelling |
doaj-aa495a98a1384a2da58609f3fa5db0222021-03-04T10:03:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8482410.1371/journal.pone.0084824The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania.Amani Thomas MoriEliangiringa Amos KaaleFrida NgalesoniOle Frithjof NorheimBjarne Robberstad<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making.<h4>Methods</h4>This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data.<h4>Findings</h4>The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised.<h4>Conclusions</h4>Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Amani Thomas Mori Eliangiringa Amos Kaale Frida Ngalesoni Ole Frithjof Norheim Bjarne Robberstad |
spellingShingle |
Amani Thomas Mori Eliangiringa Amos Kaale Frida Ngalesoni Ole Frithjof Norheim Bjarne Robberstad The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PLoS ONE |
author_facet |
Amani Thomas Mori Eliangiringa Amos Kaale Frida Ngalesoni Ole Frithjof Norheim Bjarne Robberstad |
author_sort |
Amani Thomas Mori |
title |
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. |
title_short |
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. |
title_full |
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. |
title_fullStr |
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. |
title_full_unstemmed |
The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. |
title_sort |
role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of tanzania. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
<h4>Background</h4>Insufficient access to essential medicines is a major health challenge in developing countries. Despite the importance of Standard Treatment Guidelines and National Essential Medicine Lists in facilitating access to medicines, little is known about how they are updated. This study aims to describe the process of updating the Standard Treatment Guidelines and National Essential Medicine List in Tanzania and further examines the criteria and the underlying evidence used in decision-making.<h4>Methods</h4>This is a qualitative study in which data were collected by in-depth interviews and document reviews. Interviews were conducted with 18 key informants who were involved in updating the Standard Treatment Guidelines and National Essential Medicine List. We used a thematic content approach to analyse the data.<h4>Findings</h4>The Standard Treatment Guidelines and National Essential Medicine List was updated by committees of experts who were recruited mostly from referral hospitals and the Ministry of Health and Social Welfare. Efficacy, safety, availability and affordability were the most frequently utilised criteria in decision-making, although these were largely based on experience rather than evidence. In addition, recommendations from international guidelines and medicine promotions also influenced decision-making. Cost-effectiveness, despite being an important criterion for formulary decisions, was not utilised.<h4>Conclusions</h4>Recent decisions about the selection of essential medicines in Tanzania were made by committees of experts who largely used experience and discretionary judgement, leaving evidence with only a limited role in decision-making process. There may be several reasons for the current limited use of evidence in decision-making, but one hypothesis that remains to be explored is whether training experts in evidence-based decision-making would lead to a better and more explicit use of evidence. |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24416293/pdf/?tool=EBI |
work_keys_str_mv |
AT amanithomasmori theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT eliangiringaamoskaale theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT fridangalesoni theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT olefrithjofnorheim theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT bjarnerobberstad theroleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT amanithomasmori roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT eliangiringaamoskaale roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT fridangalesoni roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT olefrithjofnorheim roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania AT bjarnerobberstad roleofevidenceinthedecisionmakingprocessofselectingessentialmedicinesindevelopingcountriesthecaseoftanzania |
_version_ |
1714806731629920256 |